Trial of Antisense Oligonucleotide Tofersen for <i>SOD1</i> ALSNew England Journal of MedicineSeptember 21, 202210.1056/nejmoa2204705Cited by 850SaveCiteExport RISWatch citationsRelated PapersNo related papers foundPowered by citation graph analysis